RWM
NGEN

Revisor Wealth Management’s NervGen Pharma NGEN Stock Holding History

Revisor Wealth Management’s Portfolio NGEN Stock Details NGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$21.8K Buy
+10,600
New +$32.9K 0.01% 368

Other funds holding NGEN

TCM
Traynor Capital Management Malvern, Pennsylvania $2.18B AUM 62.36% 1-Year Est. Return
PFGIA
Patriot Financial Group Insurance Agency Westborough, Massachusetts $974M AUM 29.77% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
APW
Aventura Private Wealth Aventura, Florida $326M AUM 34.36% 1-Year Est. Return

Revisor Wealth Management's NGEN Position: Q2 2026 in Review

Revisor Wealth Management opened a new position in NervGen Pharma (NGEN) in Q2 2026: 10,600 shares worth $21.8K. The stake represents 0.01% of the portfolio and ranks #368 among its holdings.

5 funds tracked by Wall St. Rank hold NGEN as of Q2 2026.

  • Revisor Wealth Management held 10,600 shares of NervGen Pharma worth $21.8K as of Q2 2026.
  • NervGen Pharma was a new Revisor Wealth Management position in Q2 2026.
  • NervGen Pharma made up 0.01% of Revisor Wealth Management's portfolio in Q2 2026, its #368 holding.
  • 5 funds tracked by Wall St. Rank held NervGen Pharma as of Q2 2026.

Based on Revisor Wealth Management's 13F filing for Q2 2026, filed 22 Jul 2026.